Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
20.46%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth20.46%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
3.08%
60%
—
—
Never
—
5 Years
Score—
Net Growth3.08%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Alx Oncology Holdings fundamental performance
Across Alx Oncology Holdings 's full reported history, from 2020 to 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 45M to -$ 101M. Revenue increased in 0% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.01 | — |
1 Year2025-08-12 | $ 0.62 | 226.78% |
5 Years2021-08-12 | $ 66.41 | -96.97% |
All Time2020-07-17 | $ 30.00 | -93.30% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-07-17 |
|---|---|---|---|---|
| Price | $ 2.01 | $ 0.62 | $ 66.41 | $ 30.00 |
| Return | — | 226.78% | -96.97% | -93.30% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 80M | $ 138M |
| 2025 | $ 0.00 | -$ 101M | $ 44M |
| 2024 | $ 0.00 | -$ 134M | $ 127M |
| 2023 | $ 0.00 | -$ 160M | $ 182M |
| 2022 | $ 0.00 | -$ 123M | $ 266M |
| 2021 | $ 0.00 | -$ 83M | $ 363M |
| IPO2020 | $ 1M | -$ 45M | $ 434M |
Explore beyond ALXO
You're looking at Alx Oncology Holdings . Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
